Lloyd Conover, 93, died on March 11 in St. Petersburg, Fla. “In 1952, Lloyd invented the broad-spectrum antibiotic tetracycline. This discovery grew from a scientific hunch: Working with a team that had determined the chemical structures of two Pfizer antibiotics, Aureomycin and Terramycin, Lloyd intuited that since the recently deduced chemical structures of these two antibiotics were identical but for one branch of each molecule—an extra chlorine atom in Aureomycin and an additional hydroxyl group in Terramycin—these anomalous branches might be superfluous. He reasoned that if one could remove them, the resulting compound might also be therapeutically active, perhaps more so than the parent drug. Undeterred by skepticism from his colleagues as to the likelihood of success, Lloyd and a lab assistant succeeded on the first try, using an untested technique. I remember Dad coming home with a calm smile that night and happily pronouncing one word: ‘Eureka!’ ”—Kirk Conover, son

    10.1021/cen-09544-peopobits2-conoverCXD-gr1

    Lloyd Conover (Credit: Courtesy of Craig Conover)

    ACS NewsobitsLloyd ConoverPhoto of Lloyd Conover


    Zugriff

    Zugriff prüfen

    Verfügbarkeit in meiner Bibliothek prüfen

    Bestellung bei Subito €


    Exportieren, teilen und zitieren



    Titel :

    Lloyd Conover


    Erschienen in:

    Erscheinungsdatum :

    06.11.2017




    Medientyp :

    Aufsatz (Zeitschrift)


    Format :

    Elektronische Ressource


    Sprache :

    Unbekannt


    Schlagwörter :



    Hapag-Lloyd : [10 Jahre Hapag-Lloyd]

    Hapag Lloyd Aktiengesellschaft | SLUB | 1980


    Hapag-Lloyd

    Online Contents | 1997


    Germanischer Lloyd

    Online Contents | 2009


    Norddeutscher Lloyd

    Witthöft, Hans Jürgen | TIBKAT | 1997